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Introduction
The technology required to perform capnography on expired
gas is not new and its use has been considered a standard in
basic anaesthetic monitoring by the American Society of
Anesthesiologists since 1986 [1]. This contrasts with the use
of sublingual capnometry as a detector of regional
hypoperfusion [2], which is a recent application of carbon
dioxide monitoring whose use should currently be considered
investigational.
Evidence-based medicine, defined as the integration of best
research evidence with clinical expertise and patient values
[3], encourages us to use all appropriate sources of data to
inform best practice. Using the example of carbon dioxide
monitoring and its many applications, we compare the
different kinds of evidence that were required or are needed
before a health technology can earn its place in clinical
practice.
When controlled clinical trials are
unnecessary
Measurement of the magnitude and severity of adverse
outcomes following undiagnosed esophageal intubation in
anesthesia helped create the demand for an effective way to
prevent this important problem. The use of capnography to
confirm endotracheal tube placement is founded on a simple
and widely understood physiologic rationale, and the
appropriate level of evidence required before recommending
the use of a device designed to perform this function is a
demonstration that the device is safe, sensitive, and specific.
The debate has long since moved on to other aspects of
end-tidal capnography such as its use in prehospital settings
and to the inadequate dissemination of this practice
throughout critical care [4].
Colorimetric indicators of end-tidal carbon dioxide are much
simpler devices than gas analyzers, and rely on visible color
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Abstract
Carbon dioxide has been monitored in the body using a variety of technologies with a multitude of
applications. The monitoring of this common physiologic variable in medicine is an illustrative example
of the different levels of evidence that are required before any new health technology should establish
itself in clinical practice. End-tidal capnography and sublingual capnometry are two examples of carbon
dioxide monitoring that require very different levels of evidence before being disseminated widely. The
former deserves its status as a basic standard based on observational data. The latter should be
considered investigational until prospective controlled data supporting its use become available. Other
applications of carbon dioxide monitoring are also discussed.
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changes in a chemical indicator that is housed within a
disposable connector. As with a gas analyzer, prospective
users of these devices need only see evidence that the
device is safe, sensitive, and specific. Clinical experience
tells us that these devices may have real additional benefits in
terms of ease of use, cost, and applicability in a wide range
of situations.
Applications of capnography that do not require controlled
clinical trials before their use can be recommended share
similar features. They address an important clinical problem
that can easily be described using observational methods.
There is a simple rationale for monitoring a well known
physiologic variable as a way to solve the problem, and a
safe and effective device is available to carry out the function.
When controlled clinical trials might be
needed
There are other applications of carbon dioxide monitoring
that may fulfil these criteria. The key difference is the nature
of the inference that is drawn from the use of the technology
in these situations. If a capnograph or capnometer were
available, then there is no reason not to use it when
transporting patients within or between hospitals. A simple
trial might confirm that this reduces the incidence of
hypoventilation during transport [5], but a complex one would
be required to conclude, for example, that it improved
outcome when used in the prehospital period for patients
suffering from traumatic brain injury.
Capnography would surely assist in the placement of a
needle in the trachea [6] during percutaneous tracheostomy,
but if a claim were made that this was superior to an existing
method, such as bronchoscopy, then a controlled clinical trial
would be necessary to test this hypothesis [7]. As a final
example of an application that may or may not require a
controlled clinical trial before it could be disseminated, in an
interesting role reversal capnography has been used to
diagnose tracheal placement of enteral feeding tubes.
Evaluating the properties of capnography as a diagnostic test
in this setting can be done by comparing it with the ‘gold
standard’ of chest radiography [8]. Clinical experience tells
us that using this method may have a real advantage by
detecting misplacement of the tube during the insertion itself,
but we would still require a very high level of evidence to
justify replacing the existing gold standard rather than using
capnography as an adjunct to it.
When controlled clinical trials are required
Carbon dioxide is produced in the body as a product of
metabolism and transported to the lungs by the
cardiovascular system. Hence, a simple physiologic rationale
exists for using carbon dioxide monitoring to obtain
information about cellular metabolism and global perfusion.
Clinical experience and research shows that gross
disturbances in global perfusion may be reflected by end-
tidal carbon dioxide, and this can have useful applications, for
example as a prognostic marker during advanced cardiac life
support [9].
It is also possible to monitor carbon dioxide ‘upstream’ from
expired gases. Capnometry can measure partial carbon
dioxide tension (PCO2) in a regional tissue bed, and the
reason for monitoring this in critical care medicine is that
hypoperfusion causes oxygen deficit and increases tissue
carbon dioxide production. Furthermore, hypoperfusion is not
always clinically apparent. There is large body of literature
examining the significance of splanchnic hypoperfusion.
Despite research supporting the use of gastric tonometry,
this technology never earned an established role in clinical
practice. Sublingual capnometry has recently been proposed
as a measure of regional hypoperfusion that is technically
simpler and easier to apply than gastric tonometry [10,11].
Describing why occult splanchnic hypoperfusion is a clinical
problem is much more difficult than describing why
undiagnosed esophageal intubation is a problem. A clinician
using sublingual capnometry is not being asked to accept a
simple physiologic rationale but rather a complex and
controversial paradigm. Does a sublingual capnometer
reliably and accurately measure sublingual PCO2? Is lingual
tissue hypercarbia a valid surrogate for splanchnic
hypoperfusion? Most importantly, is it reasonable to infer that
interventions arising from the monitoring of sublingual PCO2
will improve any clinically meaningful outcomes?
Sublingual capnometry fulfils none of the criteria required for
a health technology to be recommended for widespread use
before there are prospective, controlled clinical data to
support it. Research and clinical expertise will always retain
equally important roles in evidence-based practice. If
research can show us that sublingual capnometry is a
superior predictor of mortality in critically ill patients than the
serum lactate concentration [2], then can it not also show us
that it is superior to an experienced clinician?
Conclusion
The level of evidence that is required before applying any
health technology in critical care medicine is highly variable.
Manufacturers and regulatory authorities are responsible for
the safety of a device, but users must assess for themselves
the clinical problem it addresses and the sturdiness of its
underlying physiologic rationale. All inferences made when
using a device should be supported by an appropriate
combination of experience and data.
Competing interests
None declared.
References
1. American Society for Anesthesiologists: Standards for Basic
Anesthetic Monitoring 2003. [http://www.asahq.org/
publicationsAndServices/standards/02.pdf#2]221
2. Marik PE, Bankov A: Sublingual capnometry versus traditional
markers of tissue oxygenation in critically ill patients. Crit
Care Med 2003, 31:818-822.
3. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes
RB:.  Evidence-based Medicine. How to Practice and Teach
EBM, 2nd ed. Edinburgh: Churchill Livingstone; 2000.
4. Kannan S, Manji M: Survey of use of end-tidal carbon dioxide
for confirming tracheal tube placement in intensive care units
in the UK. Anaesthesia 2003, 58:476-479.
5. Helm M, Schuster R, Hauke J, Lampl L: Tight control of prehos-
pital ventilation by capnography in major trauma victims. Br J
Anaesth 2003, 90:327-332.
6. Coleman NA, Power BM, van Heerden PV: The use of end-tidal
carbon dioxide monitoring to confirm intratracheal cannula
placement prior to percutaneous dilatational tracheostomy.
Anaesth Intensive Care 2000, 28:191-192.
7. Mallick A, Venkatanath D, Elliot SC, Hollins T, Nanda Kumar CG:
A prospective randomised controlled trial of capnography vs.
bronchoscopy for Blue Rhino percutaneous tracheostomy.
Anaesthesia 2003, 58:864-868.
8. Kindopp AS, Drover JW, Heyland DK: Capnography confirms
correct feeding tube placement in intensive care unit patients.
Can J Anaesth 2001, 48:705-710.
9. Levine RL, Wayne MA, Miller CC: End-tidal carbon dioxide and
outcome of out-of-hospital cardiac arrest. N Engl J Med 1997,
337:301-306.
10. Povoas HP, Weil MH, Tang W, Moran B, Kamohara T, Bisera J:
Comparisons between sublingual and gastric tonometry
during hemorrhagic shock. Chest 2000, 118:1127-1132.
11. Weil MH, Nakagawa Y, Tang W, Sato Y, Ercoli F, Finegan R,
Grayman G, Bisera J: Sublingual capnometry: a new noninva-
sive measurement for diagnosis and quantitation of severity
of circulatory shock. Crit Care Med 1999, 27:1225-1229.
Available online http://ccforum.com/content/8/4/219